Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Daiichi Sankyo
Cerilliant
Medtronic
Chubb
McKesson
Julphar
Moodys
QuintilesIMS

Generated: November 12, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017768

« Back to Dashboard

NDA 017768 describes HIBICLENS, which is a drug marketed by Molnlycke Hlth and is included in two NDAs. It is available from one supplier. Additional details are available on the HIBICLENS profile page.

The generic ingredient in HIBICLENS is chlorhexidine gluconate. There are fifty-seven drug master file entries for this compound. Sixty-seven suppliers are listed for this compound. Additional details are available on the chlorhexidine gluconate profile page.
Summary for 017768
Tradename:HIBICLENS
Applicant:Molnlycke Hlth
Ingredient:chlorhexidine gluconate
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 017768
Suppliers and Packaging for NDA: 017768
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
HIBICLENS chlorhexidine gluconate SOLUTION;TOPICAL 017768 NDA Molnlycke Health Care 0234-0575 0234-0575-04 118 mL in 1 BOTTLE (0234-0575-04)
HIBICLENS chlorhexidine gluconate SOLUTION;TOPICAL 017768 NDA Molnlycke Health Care 0234-0575 0234-0575-08 236 mL in 1 BOTTLE (0234-0575-08)

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:SOLUTION;TOPICALStrength4%
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Expired US Patents for NDA 017768

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Molnlycke Hlth HIBICLENS chlorhexidine gluconate SOLUTION;TOPICAL 017768-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Molnlycke Hlth HIBICLENS chlorhexidine gluconate SOLUTION;TOPICAL 017768-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Fuji
Accenture
Healthtrust
US Army
Mallinckrodt
Queensland Health
Citi
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.